What Everyone Ought to Know about Vulvovaginal Disease

Transcription

What Everyone Ought to Know about Vulvovaginal Disease
ANNUAL MEETING
ASCCP2016
APRIL 13, 2016
HILTON NEW ORLEANS RIVERSIDE
PRE-COURSE
What Everyone Ought to Know about Vulvovaginal Disease
www.asccp.org/2016annualmeeting
1
Meeting Information
Meeting Competencies and Objectives
The Vulvovaginal Disease course is for all clinicians dealing with
women’s health. Although vaginal and vulvar complaints are
common, many clinicians feel underprepared to deal with these
issues. This one-day workshop will cover many aspects involving
the diagnosis and treatment of these diseases
• Upon completion of this educational activity and its post-test
and evaluation tool, the learner should be able to:
Continuing Medical Education
ACCME Accreditation
The American Society for Colposcopy and Cervical Pathology is
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
physicians.
• Gain knowledge on vulvovaginal conditions and
their management
The ASCCP Pre-Course: What Everyone Ought to Know about Vulvovaginal Disease was planned and produced in accordance with
the ACCME’s Essential Areas and Elements and Updated Criteria
(see www.accme.org).
• Understand the diagnosis and treatment of vulvodynia
Continuing Medical Education Credits
• Explore the current thoughts on squamous intraepithelial
lesions, including diagnosis and treatment measures
Attendees will receive a maximum of 6.25 AMA PRA Category 1
CreditsTM. Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
• Gain knowledge on unusual vaginitis conditions
Course Educational Methods
Lectures: Each day, the learners will attend general plenary sessions related to their areas of interest. Each session will conclude
with a question and answer period led by the presenter(s) to reinforce core concepts. Throughout the lectures and question and
answer periods, faculty members utilize an Audience Response
System. The faculty uses these group responses to readdress
items not answered correctly by the target goal percentage. This
immediate feedback helps course attendees identify their own
weaknesses and allows them to follow up with the faculty onsite.
Interactive Case Study Sessions: Several interactive sessions will
be used throughout the course to test medical knowledge and
practice-based learning skills on various vulvar, vaginal and cervical conditions. Participants, in conjunction with faculty leadership,
will review cases, vote on their diagnosis and discuss what management and treatment course they would pursue and why.
Panel Discussions: For selected topics, learners will direct
questions to panels of experts on how to integrate reported
advances into their practices. Experts will present their varying
evidence-based perspectives so that learners can determine what
may be best practice in their setting.
The lectures will be available for download until May 16, 2016 at
www.asccp.org/2016annualmeeting/VDlectures
2
Instructions for Obtaining Continuing Medical
Education Credit
To complete this program successfully and receive credit and a
certificate of attendance, participants must:
• Complete the pre-test found online prior to the meeting;
• Read the program educational objectives and review and
utlize the final program;
• Sign in at the ASCCP registration desk and attend the
program;
• Complete the post-test and post-conference assessment (15
minute online survey);
• Claim credits via ASCCP webpage
CME Certificates
CME certificates will be available online after completion of the
evaluation. During the meeting, if you notice an error on your
name badge, registration letter, or any other ASCCP materials,
please stop by the registration desk so that we may correct.
Management of Disclosure of Interest and Contributed Fund
COI Disclosure Key
As an accredited provider of CME credit, ASCCP is required to comply with the
ACCME’s Standards for Commercial Support and has implemented a management
process to ensure that anyone who is in a position to affect the content of the educational activity (e.g., faculty, planners, etc.) has disclosed to us all relevant financial
relationships with any commercial interest and has ensured that those relationships
do not influence presentation materials. All faculty have agreed to base their presentations on best available evidence. ASCCP discloses to learners any financial relationship(s) to healthcare-related commercial interests existing within the past 12 months
to include the following information: 1) the name of the individual; 2) the name of the
commercial interest; and, 3) the nature of the relationship the person has with each
commercial interest. Program directors review presentation materials for possible
bias prior to the program, and potential conflicts of interest are resolved prior to the
presentation. Any discussion of off-label use of products is noted when appropriate,
as is discussion of any limitations on the information that is presented, such as data
that are preliminary or that represent ongoing research, interim analyses, and/or
unsupported opinion. Disclosures of these commitments and/or relationships are
published in the final program materials and provided from the podium so those
participants in the activity may formulate their own judgments regarding the presentation(s). The program directors and co-directors also monitor presentations for
bias and intervene as appropriate to provide balance. Under ASCCP policy, anyone
declining either to disclose or amend material to eliminate potential bias identified by
the program directors are replaced.
Medical Advisor (A)
Advisory Board (AB)
Book Author or CD Author (BA)
Book Editor (BE)
Clinical Trial Pathologist (CTP)
Clinical Trial Support (CTS)
Clinical Trial Consultant (CTC)
Consultant (C)
Consulting Medical Director
(CMD)
Consulting Pathologist (CP)
Data Steering Committeee
(DSM)
Dividends (D)
Educational Grant (EG)
Equipment Support (E)
Employee (EM)
Fee (F)
General Support (G)
Stockholder (SH)
Sub-investigator (SI)
Travel (T)
Tumor Bank QC Review (TBR)
Vaccine Advisory Committee
(VAC)
Honorarium received (H)
International Symposium
Speaker
(ISS)
Invention (I)
Licensed Patent (LP)
Medical Advisory Board (MAB)
Principle Investigator (PI)
Quality Assurance Review (QAR)
Research (RE)
Research Grant (RG)
Research Support (RS)
Royalty (R)
Salary (S)
Scientific Advisory Board (SAB)
Slide Adjudication Panel (SAP)
Speaker’s Bureau (SB)
Speaker’s Bureau Advisor (SBA)
Stockholder (SH)
Sub-investigator (SI)
Travel (T)
Tumor Bank QC Review (TBR)
Vaccine Advisory Committee
(VAC)
Data and Safety Monitoring
Board
(DSMB)
Study Consultant (SC)
The disclosures listed below are all reported disclosures of interest or potential conflicts from the 12 months preceding this activity:
2016 AM COI Disclosures
(Faculty, Program Directors, Education Committee Chairs, Staff)
Jeff Andrews, MD (Editor-In-Chief) - No financial relationships or conflict of interest
to disclose
Kevin A. Ault, MD (Education Committee Chair) - Hologic (CTS) (PI); Merck & Co, Inc
(CTS) (PI); Roche (CTS) (PI)
Lilly Brotons (Staff) - No financial relationships or conflict of interest to disclose
Kerry O. Curtis (Staff) - No financial relationships or conflict of interest to disclose
Lisa M. DeGrave (Staff) - No financial relationships or conflict of interest to disclose
Kathleen P.L. Dwyer (Staff) - No financial relationships or conflict of interest
to disclose
Hope K. Haefner, MD (Course Director & Faculty) - Merck (AB)
Robin Heine (Staff) - No financial relationships or conflict of interest to disclose
Beth C. Huff, MSN, FNP (Education Committee Chair) - No financial relationships or
conflict of interest to disclose
Sarah Jones (Staff) - No financial relationships or conflict of interest to disclose
Chanise Queen (Staff) - No financial relationships or conflict of interest to disclose
Cynthia A. Rasmussen, MD (Course Director & Faculty) - Pfizer Corp. (SH)
Kimberly Sabatano (Staff) - No financial relationships or conflict of interest
to disclose
Colleen K. Stockdale, MD, MS (Program Director) - No financial relationships or
conflict of interest to disclose
Aruna Venkatesan, MD (Faculty) - No financial relationships or conflict of interest
to disclose
Alisha Yocum (Staff) - No financial relationships or conflict of interest to disclose
What Everyone Ought to Know
about Vulvovaginal Disease
Program
Wednesday, April 13, 2016
All sessions will take place in Grand Salon A unless
otherwise noted.
7:00 AM - 8:00 AM
Registration
Foyer Grand Salon
Breakfast
Grand Ballroom A
8:00 AM - 8:15 AM
Welcome
Speakers: Hope K. Haefner, MD
Cynthia A. Rasmussen, MD
8:15 AM - 8:45 AM
Overview of Vulvar Dermatology
Speaker: Aruna Venkatesan, MD
8:45 AM - 9:15 AM
Recurrent Vaginal Candidiasis, Bacterial Vaginosis,
and Trichomonas
Speaker: Cynthia A. Rasmussen, MD
9:15 AM - 9:35 AM
Desquamative Inflammatory Vaginitis
Speaker: Hope K. Haefner, MD
4
9:35 AM - 10:00 AM
Questions and Faculty Responses
10:00 AM - 10:30 AM
Break
Grand Ballroom A
10:30 AM - 11:00 AM
Ulcers :STDs, Immunoblistering diseases
& aphthous ulcers.
Speaker: Aruna Venkatesan, MD
11:00 AM - 11:30 AM
The Lichens: Sclerous, Simplex Chronicus, and Planus
Speaker: Cynthia A. Rasmussen, MD
11:30 AM - 11:50 AM
Vaginal Dilation
Speaker: Hope K. Haefner, MD
11:50 AM - 12:15 PM
Questions and Faculty Responses
12:15 PM - 1:15 PM
Lunch
Grand Ballroom A
1:15 PM - 1:45 PM
Puzzling Cases
Speakers: Hope K. Haefner, MD
Cynthia A. Rasmussen, MD
Aruna Venkatesan, MD
1:45 PM - 2:15 PM
Genitourinary Syndrome of Menopause
1:45 PM - 2:00 PM
Atrophy
Speaker: Cynthia A. Rasmussen, MD
Course Directors
Hope K. Haefner,
MD
2:00 PM - 2:15 PM
Fissures
Speaker: Aruna Venkatesan, MD
University of Michigan
Medical Center
Ann Arbor, MI
2:15 PM - 2:45 PM
Hidradenitis Suppurativa and Crohn’s Disease
of the Vulva
Speaker: Hope K. Haefner, MD
Cindy Rasmussen,
MD
2:45 PM - 3:15 PM
Questions and Faculty Responses
3:15 PM - 3:45 PM
Break
Grand Ballroom A
3:45 PM - 4:15 PM
Puzzling Cases
Speakers: Hope K. Haefner, MD
Cynthia A. Rasmussen, MD
Aruna Venkatesan, MD
4:15 PM - 4:30 PM
Questions and Faculty Responses
4:30 PM
Adjourn
Harvard Vanguard
Medical Center
Burlington, MA
Speaker
Aruna Venkatesan,
MD
Santa Clara Valley
Medical Center/
Stanford University
San Jose, California
5
Hotel Floor Plan
Grand Ballroom A
First Level
RIVERFRONT
STREETCAR DEPOT
GRAND BALLROOM
BURGUNDY
LE CROISSANT
A
N
FRONT
ENTRANCE
TO MAIN
LOBBY
POYDRAS STREET
CONCIERGE
1ST FLOOR
REGISTRATION COUNTERS
GUEST
ROOM
ELEVATORS
C
D
S
GIFT
SHOP
SIDE DRIVE
WORLD TRADE CENTER
PARKING GARAGE
CHEMIN ROYALE
1
4
7
10
13
16
19
22
2
5
8
11
14
17
20
23
3
6
9
12
15
18
21
24
GRAND SALON
CONVENTION CENTER BLVD.
Grand Salon A
6
B
TO CONVENTION CENTER
ASCCP Courses
Comprehensive Colposcopy
High Resolution Anoscopy
Beginning/intermediate colposcopist or
those in needs of updates—Gain additional
knowledge on Cervical Cancer Screening &
Management Guidelines, new concepts
about HPV screening and triage, treatment
methods, and HPV epidemiology.
This course is for those participating in
the health care of patients who have increased risk for anal cancer including MSM,
men and women with HIV disease, and
women with HPV-associated lower genital
tract disease.
July 27-30, 2016
Providence, RI
July 28-30, 2016
Providence, RI
October 26-29, 2016
Phoenix, Arizona
For more information and to register go to www.asccp.org
ASCCP Colposcopy Mentorship
Program (CMP)
Earn Your Certificate
of Completion in
Colposcopy—
Sign-Up Today!
www.asccp.org
7
Save the Date!
IFCPC 2017 World Congress
for Cervical Pathology and Colposcopy
April 4-7, 2017 | Orlando, Florida
www.ifcpc2017.com
Hosted by ASCCP
8